Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Merck Foundation partners with India to build healthcare capacity in Africa

      Merck Foundation partners with India to build healthcare capacity in Africa

      Ruby Khatun Khatun6 Jan 2018 9:30 AM IST
      Mumbai: Merck KGaA Germany launched their Merck Foundation, a non-profit company established in June 2017 at the Fourth edition of their annual "Merck...
      Voveron 1ml causes Kidney Damage: Health Ministry panel recommends toxicity check for component

      Voveron 1ml causes Kidney Damage: Health Ministry panel recommends toxicity check for component

      Ruby Khatun Khatun5 Jan 2018 5:06 PM IST
      New Delhi: Trouble seems to be mounting for pharma giant Novartis after a panel from health ministry has raised concerns over the safety of diclofenac...
      Dip in pharma exports due to shifting of manufacturing bases, market consolidation: Govt

      Dip in pharma exports due to shifting of manufacturing bases, market consolidation: Govt

      Ruby Khatun Khatun5 Jan 2018 11:00 AM IST
      New Delhi: Shifting of manufacturing bases to overseas markets by certain domestic companies and absence of blockbuster drugs going off-patent are...
      Glenmark launches biosimilar of Adalimumab

      Glenmark launches biosimilar of Adalimumab

      Ruby Khatun Khatun5 Jan 2018 10:45 AM IST
      New Delhi: Glenmark Pharmaceuticals announced the launch of Adalimumab's biosimilar under a licensing pact with Zydus group firm Cadila Healthcare,...
      Government addressing issue misleading advertisements on AYUSH Products: Naik

      Government addressing issue misleading advertisements on AYUSH Products: Naik

      Ruby Khatun Khatun5 Jan 2018 10:30 AM IST
      Replying to a question in Rajya Sabha, the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik said the government is taking...
      Infosys partners ValGenesis to enhance digitisation in life sciences

      Infosys partners ValGenesis to enhance digitisation in life sciences

      Ruby Khatun Khatun5 Jan 2018 10:15 AM IST
      LONDON: Infosys announced a new partnership with paperless validation company ValGenesis, that will bring even stronger compliance and quality...
      Bharat Biotechs typhoid vaccine gets WHO prequalification

      Bharat Biotech's typhoid vaccine gets WHO prequalification

      Ruby Khatun Khatun5 Jan 2018 10:15 AM IST
      New Delhi: The World Health Organization (WHO) has given its nod to Bharat Biotech's typhoid vaccine Typbar TCV, which has longer-lasting immunity...
      Philippines fines Sanofi, suspends clearance for Dengvaxia

      Philippines fines Sanofi, suspends clearance for Dengvaxia

      Ruby Khatun Khatun5 Jan 2018 10:00 AM IST
      MANILA: The Philippines has suspended clearance for Sanofi's dengue vaccine Dengvaxia and fined the French drugmaker a symbolic $2,000 citing...
      CMS to cover Abbotts glucose monitoring device

      CMS to cover Abbott's glucose monitoring device

      Ruby Khatun Khatun5 Jan 2018 9:45 AM IST
      Abbott Laboratories said its newly launched glucose monitoring device would be covered by the Centers for Medicare and Medicaid Services (CMS),...
      SRL Diagnostics revenue surpasses Rs 1,000 crore mark

      SRL Diagnostics revenue surpasses Rs 1,000 crore mark

      Ruby Khatun Khatun4 Jan 2018 12:30 PM IST
      New Delhi: SRL Diagnostics (SRL) announced that it has become the first Indian diagnostics company to surpass Rs 1,000 cr revenue in the calendar year...
      Dr Reddys drops 4 percent as Duvvada facility receives EIR

      Dr Reddy's drops 4 percent as Duvvada facility receives EIR

      Ruby Khatun Khatun4 Jan 2018 11:08 AM IST
      New Delhi: Shares of Dr Reddy's Laboratories fell over 4 percent in Wednesday's trade amid reports that an establishment inspection report (EIR) has...
      Hetero launches biosimilar Adalimumab in India

      Hetero launches biosimilar Adalimumab in India

      Ruby Khatun Khatun4 Jan 2018 10:45 AM IST
      New Delhi: Drug firm Hetero said it has launched its biosimilar Adalimumab, used for the treatment of rheumatoid arthritis and other auto-immune...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok